Akses terbuka Jurnal SINTA 1
Lactococcus lactis D4 Has Potential Effect to Alleviate Inflammation and Reverse Dysbiosis in Colitis Rat Model
The Indonesian Biomedical Journal · Vol. 16 No. 2 (2024) · hlm. 199–207
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2024-04-30
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
BACKGROUND: Inflammatory bowel disease (IBD) is a prevalent chronic inflammatory disorder of the gastrointestinal tract that may lead to colorectal cancer if untreated. Several medications for IBD have adverse side effects. Thus, there are high interest for searching alternative treatment to treat IBD. Lactococcus lactis D4 isolated from dadih, a traditional fermented buffalo milk product, was investigated for the effect on gut inflammation and microbial composition in the colitis rat model.METHODS: Eighteen male Sprague-Dawley rats were divided into three groups; control rats, colitis-induced rats, and colitis-induced rats treated with L. lactis D4 isolate. The control group received water, while the colitis-induced rats were given azoxymethane (AOM) and dextran sodium sulphate (DSS). Rats’ feces were collected for the analysis of gut microbiota diversity by next-generation sequencing and for the measurement of transforming growth factor (TGF)-β, nuclear factor kappa-B (NF-κB), interleukin (IL)-6, and tumor necrosis factor (TNF)-α colonic expression using reverse transcription-quantitative polymerase chain reaction (RT-qPCR).RESULTS: L. lactis D4 administration was able to reduce inflammation in colitis by decreasing IL-6 expression (0.87 vs. 0.73), while expression of TGF-β, NF-κB, and TNF-α were increased compared to the model group, suggesting a complex immunomodulatory effect. Gut microbiota sequencing revealed a similarity between the control and treatment groups, suggesting L. lactis D4 has great potential to ameliorate gut microbiota dysbiosis in colitis rats.CONCLUSION: L. lactis D4 has a beneficial effect in decreasing pro-inflammatory cytokines and is able to reserve dysbiosis in colitis rat model. Thus, L. lactis D4 might be used as a therapeutic agent for IBD.KEYWORDS: colitis, gut microbiota, inflammation, inflammatory bowel disease, Lactococcus lactis D4, probiotic, proinflammatory cytokines
Kata kunci
Jaringan kolaborasi para penulis
28 penulis · 80 tautan kepenulisan bersama · 6 lintas organisasi
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Andalas University
- Universitas Airlangga
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Muhammad Iqbal Rivai | Andalas University | 3 |
| Avit Suchitra | Andalas University | 3 |
| Yusrawati Yusrawati | Andalas University | 2 |
| Ade Sukma | Andalas University | 2 |
| Harnavi Harun | Andalas University | 2 |
| Eka Fithra Elfi | Andalas University | 1 |
| Yose Ramda Ilhami | Andalas University | 1 |
| Muhamad Irsyad | Andalas University | 1 |
| Irawati Chaniago | Andalas University | 1 |
| Liza Aulia Yusfi | Andalas University | 1 |
| Djong Hon Tjong | Andalas University | 1 |
| Muhammad Iqbal | Andalas University | 1 |
| Irwan Irwan | Andalas University | 1 |
| Arni Amir | Andalas University | 1 |
| Afriwardi Afriwardi | Andalas University | 1 |
| Nelvianti Nelson | Andalas University | 1 |
| Joserizal Serudji | Andalas University | 1 |
| Erry Gumilar | Universitas Airlangga | 1 |
| Hudila Rifa Karmia | Andalas University | 1 |
| Hardisman Hardisman | Andalas University | 1 |
| Tofrizal Tofrizal | Andalas University | 1 |
| Deddy Satriya Putra | Andalas University | 1 |
| Fadil Oenzil | Andalas University | 1 |
| Hafni Bachtiar | Andalas University | 1 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.